Science Explorer Back to mapMap
Discussion
Researcher · The University of Texas MD Anderson Cancer Center · United States

Börje S. Andersson

Börje S. Andersson publishes mostly in Hematology, Oncology and Molecular Biology, on topics such as Hematopoietic Stem Cell Transplantation, Acute Myeloid Leukemia Research and Acute Lymphoblastic Leukemia research.

ORCID 0000-0003-4761-0220 OpenAlex
World rank
#659,843
of 7,710,434 ranked researchers
Rank in United States
#224,455
of 1,627,098
Works
651
Citations
20k
Citations per work
30.9
h-index
75
i10-index 236Top 0.9% in Hematology
Börje S. Andersson

What does Börje S. Andersson research?

Börje S. Andersson's work is mostly in Medicine (65%), Biochemistry, Genetics and Molecular Biology (9%), Immunology and Microbiology (4%).

Health Sciences: 421 works · 64.6% of their workMedicine: 421 works · 64.6% of their workHematology: 249 works · 38.3% of their workOncology: 72 works · 11.0% of their workPublic Health, Environmental and Occupational Health: 59 works · 9.1% of their workGenetics: 40 works · 6.2% of their workEverything else: 143 works · 22.0% of their workLife Sciences: 87 works · 13.4% of their workBiochemistry, Genetics and Molecular Biology: 61 works · 9.3% of their workMolecular Biology: 61 works · 9.3% of their workImmunology and Microbiology: 27 works · 4.1% of their workImmunology: 27 works · 4.1% of their workTHEIR WORKBörje S.Andersson651works
Life Sciences13%Health Sciences65%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine42164.6%
  2. Everything else14322.0%
    1. Biochemistry, Genetics and Molecular Biology619.3%
    2. Immunology and Microbiology274.1%
  1. 1Hematology38% of their works
  2. 2Oncology11% of their works
  3. 3Molecular Biology9% of their works
  4. 4Public Health, Environmental and Occupational Health9% of their works
  5. 5Genetics6% of their works
  6. 6Immunology4% of their works

Research topics

Which keywords describe Börje S. Andersson's research?

The keywords of their largest research topics: Hematopoietic Stem Cells, Prognostic Factors, Bone Marrow Niche, Graft-versus-Host Disease, Acute Myeloid Leukemia, AML, Acute Lymphoblastic Leukemia and Childhood Cancer.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.

All 19 words, with their numbers
  1. Hematopoietic Stem Cells4452 topics
  2. Prognostic Factors4073 topics
  3. Bone Marrow Niche2371 topic
  4. Graft-versus-Host Disease2371 topic
  5. AML2081 topic
  6. Acute Myeloid Leukemia2081 topic
  7. Acute Lymphoblastic Leukemia1421 topic
  8. Childhood Cancer1421 topic
  9. BCR-ABL1091 topic
  10. Imatinib1091 topic
  11. Rituximab1062 topics
  12. Merkel Cell Carcinoma581 topic
  13. Polyomavirus581 topic
  14. Chronic Lymphocytic Leukemia571 topic
  15. Genomic Aberrations571 topic
  16. HDAC Inhibitors531 topic
  17. Histone Deacetylases531 topic
  18. Classification491 topic
  19. Lymphoma491 topic

Where does Börje S. Andersson work?

Börje S. Andersson's main affiliation in the publication record is The University of Texas MD Anderson Cancer Center, United States.

How many publications and citations does Börje S. Andersson have?

OpenAlex counts 651 works and 20,126 citations for Börje S. Andersson, an h-index of 75, ranking #659,843 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Börje S. Andersson. Posts are plain text and can be reported.